| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |